from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1552/frdA

LFCtreatmentdescriptionclass of inhibitor

-0.309

Amikacinug/mL Amikacintranslation

-0.454

Cap5-10ug/mL Capreomycintranslation

-0.257

Rox10-50 ug/mL Roxithromycintranslation

1.427

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.476

Rif0.2-5ug/mL Rifampicintranscription

-0.115

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.759

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.416

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.460

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.469

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.202

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.478

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.885

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.000

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.486

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.280

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.131

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.047

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.786

Nigericin50 uM Nigericinrespiration

0.171

TRC10-150 ug/mL Triclosanrespiration

0.507

TRZ10-25 ug/mL Thioridazinerespiration

-0.032

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.205

menadione6-10 ug/mL Menadionerespiration

-0.384

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.625

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.457

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.720

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.404

NRP_1Non-replicating persistence stage 1dosRassociated

-0.123

Amp0.2mg/mL AmpicillincellWall

0.062

Cephalexin20-100 ug/mL CephalexincellWall

0.479

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.281

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.297

EMB10-20 ug/mL EthambutolcellWall

-0.564

Eta12-40 ug/mL EthionamidecellWall

-0.873

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.913

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.974

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.233

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.703

BZA0.12 mg/mL BenzamidearomaticAmides

1.031

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.444

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.005

H2O24 mM hydrogen peroxideDNAdamaging

-0.507

Levo10 ug/mL LevofloxacinDNAdamaging

1.158

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.710

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.160

UVUV-irradiationDNAdamaging

0.667

ARP41-4 ug/mL Antitubercular compound ARP4?

0.315

Antimycin12.5-50 ug/mL Antimycin A?

-0.840

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.050

PA_110-50 ug/mL Antitubercular compound PA-1?

0.770

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.812

PA8240.2-2 ug/mL PA-824?

0.133

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.022

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-0.958

mercaptoethanol2 mM 2-Mercaptoethanol?

0.633

methoxatin10-20 ug/mL Methoxatin?